Critical Pharmaceuticals Receives Notice of Allowance from US Patent and Trademark Office for Intranasal Growth Hormone and Parathyroid Hormone Products
Critical Pharmaceuticals today announces that the United States Patent and Trademark Office (USPTO) has issued a notice…